Challenges And Best Practices For Developing Antibody Drug Conjugates (ADCs)

This webinar offers a detailed exploration of antibody-drug conjugates (ADCs) as transformative cancer therapies, led by Parexel’s team of regulatory specialists with extensive experience as former regulators. Through this workshop, participants will gain insights into the development and evaluation of ADCs, from preclinical research to manufacturing intricacies (CMC) and clinical advancements. The session highlights key challenges, pivotal considerations, and groundbreaking developments that position ADCs as a promising innovation in oncology.